(Q36848145)

16 August 2017

Paclitaxel gelatin nanoparticles for intravesical bladder cancer therapy (English)

1 reference

16 August 2017

1 reference

1 reference

1 reference

Ze Lu

1

1 reference

16 August 2017

Teng-Kuang Yeh

2

1 reference

16 August 2017

Jie Wang

3

1 reference

16 August 2017

Ling Chen

4

1 reference

16 August 2017

Greg Lyness

5

1 reference

16 August 2017

Yan Xin

6

1 reference

16 August 2017

M Guillaume Wientjes

7

1 reference

16 August 2017

Valerie Bergdall

8

1 reference

16 August 2017

Guillermo Couto

9

1 reference

16 August 2017

Francisco Alvarez-Berger

10

1 reference

16 August 2017

Carrie E Kosarek

11

1 reference

16 August 2017

Jessie L-S Au

12

1 reference

16 August 2017

language of work or name

English

0 references

publication date

19 February 2011

1 reference

16 August 2017

1 reference

16 August 2017

185

1 reference

16 August 2017

4

1 reference

16 August 2017

1478-1483

1 reference

Predictors of intravesical therapy for nonmuscle invasive bladder cancer: results from the surveillance, epidemiology and end results program 2003 patterns of care project

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3655418

Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3655418

Effects of carrier on disposition and antitumor activity of intraperitoneal Paclitaxel

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3655418

Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3655418

Bladder cancer clinical guidelines panel summary report on the management of nonmuscle invasive bladder cancer (stages Ta, T1 and TIS). The American Urological Association

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3655418

Preliminary experience with paclitaxel in advanced bladder cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3655418

Taxol-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3655418

Comparative preclinical and clinical pharmacokinetics of a cremophor-free, nanoparticle albumin-bound paclitaxel (ABI-007) and paclitaxel formulated in Cremophor (Taxol).

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3655418

A method to study drug concentration-depth profiles in tissues: mitomycin C in dog bladder wall.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3655418

Words of wisdom. Re: predictors of intravesical therapy for nonmuscle invasive bladder cancer: results from the Surveillance, Epidemiology and End Results Programme (SEER) 2003 Patterns of Care Project.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3655418

Effect of dimethyl sulfoxide on bladder tissue penetration of intravesical paclitaxel.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3655418

An alternative paclitaxel microemulsion formulation: hypersensitivity evaluation and pharmacokinetic profile

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3655418

Computational model of intracellular pharmacokinetics of paclitaxel.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3655418

Plasma pharmacokinetics and tissue distribution of paclitaxel in CD2F1 mice

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3655418

Pharmacokinetics of intravesical mitomycin C in superficial bladder cancer patients.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3655418

In vitro investigations of new therapeutic agents on bladder tumor cell lines

5 September 2018

1 reference

12 December 2020

Methods to improve efficacy of intravesical mitomycin C: results of a randomized phase III trial

1 reference

12 December 2020

Determinants of paclitaxel penetration and accumulation in human solid tumor

1 reference

12 December 2020

Bladder wall penetration of intravesical mitomycin C in dogs

1 reference

12 December 2020

Cremophor reduces paclitaxel penetration into bladder wall during intravesical treatment

1 reference

12 December 2020

Paclitaxel-loaded gelatin nanoparticles for intravesical bladder cancer therapy

1 reference

12 December 2020

Solid-state characterization of paclitaxel

1 reference

12 December 2020

Bladder tissue pharmacokinetics of intravesical taxol

1 reference

12 December 2020

Pharmacologic effects of paclitaxel in human bladder tumors

1 reference

12 December 2020

Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinum-pretreated ovarian cancer patients

1 reference

12 December 2020

Bladder tissue uptake of mitomycin C during intravesical therapy is linear with drug concentration in urine

1 reference

12 December 2020

Nonlinear pharmacokinetics of paclitaxel in mice results from the pharmaceutical vehicle Cremophor EL

1 reference

12 December 2020

p53 and treatment of bladder cancer

1 reference

12 December 2020

10.1016/J.JURO.2010.11.091

Identifiers

DOI

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

21334664

1 reference